【出版时间及名称】：2009年12月印度制药行业研究报告
        【作者】：centrum证券
        【文件格式】：PDF
        【页数】：70
        【目录或简介】：
Table of Contents
Executive Summary……………………………………………………………………5
Investment Arguments
Generics – Key growth driver…………………………………………………...…….7
Bullish on CRAMS story ……………………………………………………………...15
India – among fastest growing nations in formulations………………………….19
Premium valuations justified ……………………………………………………….23
Companies
Dr Reddy's Labs ……………………………………………………..………27
Ranbaxy Laboratories ………………………………………………………39
Glenmark Pharma……………………………………………………….….51
Aurobindo Laboratories …………………………………………….……..53
Jubilant Organosys ………………………………………………….……..55
Ipca Labs ………………………………………………………………..…..57
Sun Pharma ………………………………………………………………..59
Cipla ……………………………………………..………………………....61
Piramal Healthcare ………………………………………………………..63
Dishman Pharma ………………………………………………..………..65
Biocon ……………………………………………………………………..67